by SXHH Marketing | Apr 17, 2026 | Hormone Replacement Therapy, Wellness
If you are experiencing:
• Irregular periods
• Mood swings
• Fatigue
• Hot flashes
• Night sweats
It may be signs of hormonal imbalance, but don’t worry, HerKare is here to help.
Now Offering: Women’s Comprehensive Hormone Testing
HerKare is making hormonal testing easier than ever with our new offer. For a limited time, HerKare is offering two paths to Comprehensive Hormone Evaluations for all new patients:
- Insurance Coverage
HerKare works with most major insurance plans, which means your hormone test could be covered.
You pay your specialist copay, that’s it.
Want to check your coverage? Call your nearest HerKare clinic and a member of our team will be happy to help.
Coverage varies by plan. Deductibles and out-of-pocket costs may apply.
- Self-Pay
Don’t have insurance? Prefer to pay out-of-pocket? We’ve got you covered.
Discounted from $200, you only pay a $99 flat fee.
What’s Included?
Our Women’s Comprehensive Hormone Evaluation includes:
• 65+ biomarker hormone panel
• Lipid panel and comprehensive metabolic panel
• Autonomic Nervous System (ANS) test
• InBody body composition scan
• Consultation with a licensed provider
Your First Step Starts Here
This offer is only available for a limited time, so don’t walk, run to your nearest HerKare clinic. Call or book an appointment today!
Terms and conditions apply. Offer open to new patients only. If patients choose to begin hormone replacement therapy, they must remain on their chosen path (insurance or self-pay) for the entire calendar year. Patients with high-deductible plans should ask their provider which option is best for them.
by SXHH Marketing | Apr 14, 2026 | Wellness
Low libido in women is more common than you think, especially during life stages like perimenopause and hormonal changes.
Some women find themselves at a crossroads; daily pills must follow a schedule, and hormone therapy may feel like a commitment you’re not quite ready for. But now, there’s another option: PT-141
PT-141 has been gaining attention as a treatment for women experiencing a low sex drive. FDA approved, this option gives women another way to take control of their sexual health.
But first, what is PT-141 and why has it become a part of the conversation surrounding women’s sexual health?
What is PT-141
PT-141, also known as bremelanotide, is a peptide injection used to treat low sexual desire. Unlike other sexual health drugs that increase blood flow, PT-141 works in the brain.
PT-141 works by acting on a part of the brain called the hypothalamus, which controls mood, pleasure, and sexual desire. It sends signals to the brain that increase dopamine (the “happy chemical”), that in turn boosts attraction and feelings of interest, not just physical responses.
PT-141 affects both the body and the brain to support a complete experience when it comes to intimacy.
Now that we have a better understanding of what PT-141 is and how it works, what makes it so appealing for women?
Why Women in Perimenopause Are Exploring PT-141
PT-141 is making its rounds in conversations when it comes to women’s health. You may have seen healthcare providers or wellness experts discussing it on social media as more women are beginning to explore its potential.
PT-141 is not just another peptide; it is a targeted option that’s helping many women rediscover the confidence and desire they’ve lost.
But with any treatment, proper evaluation is needed. PT-141 is not a one-size-fits-all, and it is important to determine whether it is right for you.
At HerKare, we are now offering PT-141 as we expand care for women’s sexual health.
PT-141 for Women in Texas: Now Available at HerKare
As interest in this treatment continues to grow, more women are asking whether PT-141 is right for them. No more Googling or Reddit surfing. PT-141 is now available at HerKare for women who are looking to reignite that sexual desire and support their overall wellbeing.
At HerKare, we believe that every woman is unique, so when it comes to treatment, nothing is ever one-size-fits-all. PT-141 can be used as a standalone treatment or an add-on to ensure optimized wellness.
Curious whether PT-141 could be an option for you? Our HerKare providers are here to guide you through the next steps, book an appointment today!
Bremelanotide (subcutaneous route) – Side effects & dosage – Mayo Clinic
by SXHH Marketing | Feb 12, 2026 | Uncategorized
By Carolyn Moyers, D.O., FACOG
Are you taking, or considering, hormone replacement therapy (HRT) to treat bothersome menopause symptoms? How does this impact your heart health?
There has been controversy around hormone replacement therapy (HRT) over past decades. HRT has gone from a standard treatment for hot flashes and other symptoms of menopause to a decision each woman must weigh carefully based on her body and health history.
Some research has linked HRT to increased risk of heart disease, stroke, blood clots, and breast cancer, while other studies have shown hormone replacement may lower the risk of osteoporosis and improve other aspects of health.
Read the literature on this and your head will be spinning. Recent studies are showing benefits to women, particularly women who use HRT close to the onset of menopause, although, the duration of therapy and relationship to heart health awaits further study.
Hormone replacement therapy – estrogen, estrogen + progesterone, and dare you add testosterone – It’s all so confusing. “What are my risks?” patient’s often ask.
Risks in perspective
- The risk of heart disease to an individual woman taking hormone therapy is very low.
- Your individual risk of developing heart disease depends on many factors, including family medical history, personal medical history and lifestyle practices.
- If you stopped having periods or lost normal function of your ovaries before age 40, you have a different set of heart and blood vessel (cardiovascular) health risks compared with women who reach menopause near the average age of about 50. This includes a higher risk of coronary heart disease.
Talk to your provider about your personal risks. If you’re at low risk of heart disease, and your menopausal symptoms are significant, hormone therapy is a reasonable consideration.
HRT risks may vary depending on:
- Whether estrogen is given alone or with a progesterone
- Your current age and age at menopause
- The dose, type of estrogen and how you take it (oral, transdermal, transvaginal)
- Other health risks, such as your family medical history and cancer risks
Who should NOT take hormone therapy?
If you’ve already had a heart attack, HRT is not for you. If you already have heart disease or you have a history of blood clots, the risks of hormone therapy have been clearly shown to outweigh any potential benefits.
Menopause symptoms: What are they and why are women seeking treatment?
As women age, they find themselves with sudden sensation of extreme heat in the upper body, face, neck and chest, referred to as a hot flush. The unwelcome sweating, flushing, chills, clamminess, anxiety and even heart palpitations accompany this. These unwelcome vasomotor symptoms vary in how often and how long they last. Patients report symptoms lasting anywhere from 4-10 years around menopause. While menopause is defined as not having cycles for 12 months, symptoms do not end with the end of menstrual cycles. Sigh . . . The low estrogen levels leads to changes in the vagina– vaginal or vulvar dryness, discharge, itching and painful intercourse. The lack of estrogen leads to a loss of superficial epithelial cells, vaginal folds and elasticity and narrowing and shortening of the vagina. In addition, the pH of the vagina even changes and can lend to more urogenital infections. “Really?!” I hear you asking yourself. All these changes have women feeling frustrated, fatigued and often questioning their sanity.
HRT and the Heart
The consensus at this time is that menopausal hormone replacement therapy should not be used for the primary prevention of coronary heart disease. There is some data that supports a “timing hypothesis” – meaning, the cardiovascular benefit is most profound when HRT is used at the onset of menopause versus someone who has been menopausal 10 years or more. We do not know the affects of the duration of HRT at this time.
Your provider will likely recommend a heart healthy lifestyle to reduce your cardiovascular risks.
- Don’t smoke or use tobacco products.
- Get regular physical activity.
- Eat a healthy diet focusing on fruits, vegetables, whole grains and low-fat protein.
- Maintain a healthy weight.
- Get regular health screenings to check your blood pressure and cholesterol levels to detect early signs of heart disease.
We also understand that quality of life must be considered when prescribing HRT. Lifestyle changes and over the counter solutions don’t always provide the relief you so desperately desire. HRT must be individualized based on each woman’s risk-benefit ratio and clinical presentation.
How is HRT different at HerKare?
A customized treatment plan specific to each patient is designed to improve symptoms. The goal is to achieve a balance of hormones, vitamin deficiencies, and thyroid function.
A balancing act
Among U.S. women, nearly 1 in 4 deaths each year is due to heart and blood vessel (cardiovascular) disease. Women of all ages should take heart disease seriously.
Most healthy women can safely take HRT for menopausal symptoms without significantly increasing the risk of heart disease. If you experience classic menopausal symptoms talk to your provider about how you can relieve troublesome symptoms without putting your health at risk.
by SXHH Marketing | Dec 12, 2025 | Hormone Replacement Therapy, Menopause, Wellness
For years, menopausal hormone therapy carried a warning label that did more than flag risk. It shaped perception. It ended conversations before they started. For many women, it quietly reinforced the idea that relief came with a price that was simply too high.
The FDA has now removed the black box warning from certain menopausal hormone therapy products, and the significance of that change goes beyond labeling. It signals a long-overdue recalibration in how women’s hormone care is understood.
How we got here
The warning traces back to the Women’s Health Initiative studies published in the early 2000s. Those findings linked specific hormone therapies to increased risks of blood clots, stroke, and breast cancer in certain populations.
What mattered then, and still does, is context.
The study primarily examined older women, often more than a decade past menopause, and prescribed oral hormone formulations that reflected clinical norms of the time. The results were meaningful, but their application became sweeping. A single narrative took hold, flattening nuance and leaving little room for clinical judgment or individual variation.
Why the warning no longer made sense
Two decades later, menopausal hormone therapy looks fundamentally different.
Research has continued. Clinical practice has evolved. The conversation around timing, formulation, dosing, and patient selection has grown more precise. We now understand that hormone therapy initiated closer to menopause carries a different risk profile than therapy started years later. We understand that delivery method matters. We understand that cardiovascular and metabolic health cannot be separated from hormone decisions.
The FDA’s decision to remove the black box warning reflects this accumulation of knowledge. It acknowledges that the label no longer aligned with how menopausal hormone therapy is prescribed or evaluated today.
Why this matters to women now
The black box warning informed, but it also created fear in women who could have benefited from HRT.
For many women, it became shorthand for danger, reinforcing hesitation even as symptoms mounted. Brain fog. Disrupted sleep. A persistent sense of being off balance. Mood changes that felt unfamiliar. A body that no longer responded the way it once did.
The removal of the warning does not suggest that hormone therapy is universally appropriate. What it does is restore the possibility of discussion without fear of being the loudest voice in the room.
What has not changed
Hormone therapy remains a medical intervention that requires discernment.
Women considering menopausal hormone therapy should expect:
-
An individualized medical evaluation
-
Careful attention to health history and risk factors
-
Dosing that reflects both symptoms and physiology
-
Ongoing monitoring over time
The shift is not toward casual prescribing. It is toward care that reflects current science rather than outdated generalizations.
Where HerKare stands
At HerKare, menopausal hormone therapy is approached as a collaborative, patient-focused process. Care is shaped by how a woman feels, what her labs reveal, and how her health evolves.
by SXHH Marketing | Oct 23, 2025 | Hormone Replacement Therapy, Menopause, Sleep, Wellness
Every October, National Menopause Awareness Month encourages women to understand the changes happening in their bodies, and to know that help and hope are available.
Menopause is a natural life stage, but that doesn’t mean it’s easy to navigate. At HerKare, we believe every woman deserves care, compassion, and accurate information during this transition.
What Is Menopause?
Menopause marks the end of a woman’s menstrual cycles, confirmed after 12 months without a period. The average age is 51, but symptoms can begin years earlier during perimenopause.
As estrogen and progesterone levels fluctuate, your body may react in ways that feel unfamiliar. Recognizing these changes early can make them easier to manage.
Common Signs and Symptoms
-
Hot flashes or night sweats
-
Irregular or missed periods
-
Mood changes or anxiety
-
Fatigue and low motivation
-
Vaginal dryness or discomfort
-
Weight gain or slower metabolism
-
Hair thinning or dry skin
-
Memory lapses or “brain fog”
Every woman’s experience is unique. Some may only notice mild changes, while others face symptoms that affect sleep, work, and relationships.
Why Menopause Awareness Matters
For decades, conversations about menopause were quiet, even taboo. Women were told to “push through.” Today, Menopause Awareness Month reminds us that these symptoms are real—and treatable.
When hormones decline, it can impact bone health, heart health, metabolism, and mental well-being. Awareness leads to proactive care and better long-term health.
“At HerKare, our message is simple: Menopause isn’t the end of feeling like yourself—it’s a new beginning,” says Michael Seay, MSN, APRN, NP-C. “When you understand your hormones, you can take control of your energy, mood, and confidence again.”
How HerKare Can Help
HerKare offers a full spectrum of care for women in perimenopause and menopause, including:
-
Comprehensive hormone testing
-
Individualized hormone replacement therapy (HRT)
-
Lifestyle and nutrition guidance
-
Ongoing follow-up care to track progress and fine-tune your treatment
Our goal is to help you rediscover balance, clarity, and comfort, so you can feel strong and joyful through every stage of life.
This Menopause Awareness Month, make yourself a priority. Schedule a free consultation and start feeling like you again.
